tiprankstipranks
Analyst Profile
Followed by 60 other investors
.
Jason Bednar

Jason Bednar

Piper Sandler
Wall Street Analyst
Ranked #6,808 out of 8,045 Analysts on TipRanks (#18,212 out of 21,519 overall experts)

Success Rate

41%
49 out of 120 Profitable Transactions

Average Return

-3.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Jason Bednar's ratings since 2020 and opened each position for the duration of 1 Year:
40.83% of your transactions would have been profitable with an average return of -3.1%

Stock Rating Distribution

186Ratings
77.96% Buy
19.89% Hold
2.15% Sell
Distribution of Jason Bednar's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
NovoCure Ltd.
(NVCR)
Rating Type:Buy
Dates:Jul 10, 2020 - Jul 10, 2021
Gain:222.20%
The most profitable rating made by Jason Bednar

Jason Bednar's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
VAR
Varian Medical Systems
Aug 02, 2020
Hold
Downgraded
71%
+5.30%
10
MDxHealth S.A. Sponsored ADR
Nov 29, 2021
Buy
Initiated
$15.00
(83.60% Upside)
0%
-5.70%
1
Alpha Tau Medical Ltd
Apr 08, 2022
Buy
Initiated
$19.00
(76.09% Upside)
0%
-6.00%
1
REPRO-MED Systems
May 05, 2022
Hold
Reiterated
$3.00
(20.00% Upside)
0.00%
1
EDAP TMS
May 18, 2022
Buy
Reiterated
$11.00
(43.60% Upside)
50%
-0.35%
3
Patterson Companies
Jun 29, 2022
Buy
Reiterated
$42.00
(36.99% Upside)
67%
+0.07%
13
Merit Medical Systems
Jul 01, 2022
Buy
Reiterated
$70.00
(10.10% Upside)
33%
+3.60%
3
Cooper Co
Jul 08, 2022
Buy
Reiterated
$375.00
(12.50% Upside)
17%
-12.73%
7
DENTSPLY SIRONA
Jul 11, 2022
Hold
Reiterated
$38.00
(1.06% Upside)
56%
+1.44%
14
Align Tech
Jul 22, 2022
Buy
Reiterated
$370.00
(29.28% Upside)
27%
-13.96%
19
List of latest recommendations made by Jason Bednar. Click to expand and see Jason Bednar's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More